Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys)

In recent months, several SARS-CoV-2 variants have emerged that enhance transmissibility and escape host humoral immunity. Hence, the tracking of viral evolutionary trajectories is clearly of great importance. Little is known about SARS-CoV-2 evolution in nonhuman primate models used to test vaccines and therapies and to model human disease. Viral RNA was sequenced from rectal swabs from Chlorocebus aethiops (African green monkeys) after experimental respiratory SARS-CoV-2 infection. Two distinct patterns of viral evolution were identified that were shared between all collected samples. First, mutations in the furin cleavage site that were initially present in the virus as a consequence of VeroE6 cell culture adaptation were not detected in viral RNA recovered in rectal swabs, confirming the necessity of this motif for viral infection in vivo. Three amino acid changes were also identified; ORF 1a S2103F, and spike D215G and H655Y, which were detected in rectal swabs from all sampled animals. These findings are demonstrative of intra-host SARS-CoV-2 evolution and may identify a host-adapted variant of SARS-CoV-2 that would be useful in future primate models involving SARS-CoV-2 infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Viruses - 14(2022), 1 vom: 01. Jan.

Sprache:

Englisch

Beteiligte Personen:

Rowe, Lori A [VerfasserIn]
Beddingfield, Brandon J [VerfasserIn]
Goff, Kelly [VerfasserIn]
Killeen, Stephanie Z [VerfasserIn]
Chirichella, Nicole R [VerfasserIn]
Melton, Alexandra [VerfasserIn]
Roy, Chad J [VerfasserIn]
Maness, Nicholas J [VerfasserIn]

Links:

Volltext

Themen:

African green monkey (Chlorocebus aethiops)
Evolution
Journal Article
ORF1ab polyprotein, SARS-CoV-2
Polyproteins
RNA, Viral
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2
Viral Proteins

Anmerkungen:

Date Completed 04.02.2022

Date Revised 05.11.2023

published: Electronic

Citation Status MEDLINE

doi:

10.3390/v14010077

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM335968732